
Picard Medical announced a $5 million offering of common stock and warrants priced at $0.30 per share to institutional investors. The proceeds will be used for working capital and to pay off senior secured notes and loans. The offering includes new warrants with exercise prices of $0.35, exercisable immediately, and expiring in 2 to 5 years. This financing move supports Picard Medical's ongoing operations and growth as the maker of the FDA-approved SynCardia Total Artificial Heart.